Market Cap 106.47M
Revenue (ttm) 0.00
Net Income (ttm) -10.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 129,800
Avg Vol 336,704
Day's Range N/A - N/A
Shares Out 33.38M
Stochastic %K 10%
Beta 0.49
Analysts Strong Sell
Price Target $10.00

Company Profile

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 708 9808
Address:
3150 Almaden Expressway, Suite 250, San Jose, United States
research_WTR
research_WTR Jan. 21 at 7:54 PM
Initiation of Coverage: Anixa Biosciences, Inc. (NASDAQ: $ANIX) Advancing Novel T-Cell & Vaccine Programs in Cancer WTR has initiated coverage on Anixa, a clinical-stage biotech developing next-generation immunotherapies and vaccines targeting ovarian and breast cancer. Read Robert Sassoon's full report to learn more about Anixa’s differentiated platforms, clinical progress, and market opportunity. https://www.watertowerresearch.com/doc?docID=IOC_ANIX_12012025 $ANIX #Biotech #CancerResearch #Immunotherapy #CellTherapy #Oncology #BreastCancer #OvarianCancer #ClinicalTrials #SmallCaps #WaterTowerResearch #WTRSpotlight @AnixaBio
0 · Reply
stockobserver51
stockobserver51 Jan. 16 at 7:52 PM
$ANIX Despite brief resuscitation efforts, oxygen is lacking again.
0 · Reply
Pedelco
Pedelco Jan. 14 at 8:37 PM
$ANIX fuck cancer, Super bullish
0 · Reply
gziwiss
gziwiss Jan. 12 at 10:56 PM
$ANIX what cause delay on earning?
0 · Reply
d_risk
d_risk Jan. 12 at 10:03 PM
$ANIX - Anixa Biosciences Inc. Common Stock - 10K - Updated Risk Factors ANIX flags heightened uncertainty around novel CAR-T development, tougher patient enrollment and vaccine hesitancy, new supply chain vulnerabilities for cell therapy inputs, and more complex trial, partnership, and IP litigation risks, while financial risk language stays largely the same aside from updated numbers. #Biotechnology #IntellectualProperty #SupplyChainRisk #ClinicalTrials #CellTherapy 🟢 Added 🟠 Removed https://d-risk.ai/ANIX/10-K/2026-01-12
0 · Reply
stockobserver51
stockobserver51 Jan. 12 at 10:04 AM
$ANIX Sorry, it was December 15, 2025.
0 · Reply
stockobserver51
stockobserver51 Jan. 10 at 9:37 PM
$ANIX 5, ha ha ha, that statement makes me want to vomit. We investors have been hearing this from these spin doctors about this stock for years, and for more than eight years it has been in freefall. Only people who are involved in the company themselves or who lure others into investing in it in order to rip them off can make such predictions. Furthermore, there are so-called analysts who have even predicted up to $10 for this stock, which hasn't come close to happening. These wannabe analysts are probably invested in this losing stock themselves. "Don't get ripped off." The CEO is incredibly arrogant and, according to statements in the interview from December 15, 2024, has no interest in the stock price or the investors. Only when his opinion changes will the stock price improve for the investors.
0 · Reply
Pedelco
Pedelco Jan. 10 at 1:18 PM
$ANIX back to 5$
0 · Reply
EK12
EK12 Jan. 9 at 9:06 PM
$ANIX Are they reporting today?
1 · Reply
ChessHere
ChessHere Jan. 9 at 8:54 PM
$ANIX imagine that - i got the fuck out of Anix after being a 7+ year bag holder - selected 20 stocks i see as winners for 2026 and I am already up over 7k in less than a week . Why the hell did I let Amit suck me in so bad - guess I gave into the emotion of wanting to see a therapy for breast cancer instead of common sense where all Amit does is talk, talk, talk, while paying himself millions
3 · Reply
Latest News on ANIX
Anixa Biosciences: Oncology Platform With Asymmetric Upside

Jul 15, 2025, 3:49 PM EDT - 6 months ago

Anixa Biosciences: Oncology Platform With Asymmetric Upside


Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Jun 20, 2025, 7:30 AM EDT - 7 months ago

Anixa Biosciences to Host an Investor Webcast on June 26, 2025


research_WTR
research_WTR Jan. 21 at 7:54 PM
Initiation of Coverage: Anixa Biosciences, Inc. (NASDAQ: $ANIX) Advancing Novel T-Cell & Vaccine Programs in Cancer WTR has initiated coverage on Anixa, a clinical-stage biotech developing next-generation immunotherapies and vaccines targeting ovarian and breast cancer. Read Robert Sassoon's full report to learn more about Anixa’s differentiated platforms, clinical progress, and market opportunity. https://www.watertowerresearch.com/doc?docID=IOC_ANIX_12012025 $ANIX #Biotech #CancerResearch #Immunotherapy #CellTherapy #Oncology #BreastCancer #OvarianCancer #ClinicalTrials #SmallCaps #WaterTowerResearch #WTRSpotlight @AnixaBio
0 · Reply
stockobserver51
stockobserver51 Jan. 16 at 7:52 PM
$ANIX Despite brief resuscitation efforts, oxygen is lacking again.
0 · Reply
Pedelco
Pedelco Jan. 14 at 8:37 PM
$ANIX fuck cancer, Super bullish
0 · Reply
gziwiss
gziwiss Jan. 12 at 10:56 PM
$ANIX what cause delay on earning?
0 · Reply
d_risk
d_risk Jan. 12 at 10:03 PM
$ANIX - Anixa Biosciences Inc. Common Stock - 10K - Updated Risk Factors ANIX flags heightened uncertainty around novel CAR-T development, tougher patient enrollment and vaccine hesitancy, new supply chain vulnerabilities for cell therapy inputs, and more complex trial, partnership, and IP litigation risks, while financial risk language stays largely the same aside from updated numbers. #Biotechnology #IntellectualProperty #SupplyChainRisk #ClinicalTrials #CellTherapy 🟢 Added 🟠 Removed https://d-risk.ai/ANIX/10-K/2026-01-12
0 · Reply
stockobserver51
stockobserver51 Jan. 12 at 10:04 AM
$ANIX Sorry, it was December 15, 2025.
0 · Reply
stockobserver51
stockobserver51 Jan. 10 at 9:37 PM
$ANIX 5, ha ha ha, that statement makes me want to vomit. We investors have been hearing this from these spin doctors about this stock for years, and for more than eight years it has been in freefall. Only people who are involved in the company themselves or who lure others into investing in it in order to rip them off can make such predictions. Furthermore, there are so-called analysts who have even predicted up to $10 for this stock, which hasn't come close to happening. These wannabe analysts are probably invested in this losing stock themselves. "Don't get ripped off." The CEO is incredibly arrogant and, according to statements in the interview from December 15, 2024, has no interest in the stock price or the investors. Only when his opinion changes will the stock price improve for the investors.
0 · Reply
Pedelco
Pedelco Jan. 10 at 1:18 PM
$ANIX back to 5$
0 · Reply
EK12
EK12 Jan. 9 at 9:06 PM
$ANIX Are they reporting today?
1 · Reply
ChessHere
ChessHere Jan. 9 at 8:54 PM
$ANIX imagine that - i got the fuck out of Anix after being a 7+ year bag holder - selected 20 stocks i see as winners for 2026 and I am already up over 7k in less than a week . Why the hell did I let Amit suck me in so bad - guess I gave into the emotion of wanting to see a therapy for breast cancer instead of common sense where all Amit does is talk, talk, talk, while paying himself millions
3 · Reply
Aionle
Aionle Jan. 9 at 2:15 PM
0 · Reply
TDMF123
TDMF123 Jan. 9 at 11:45 AM
$ANIX if I’m not mistaken, earnings will be reported after hours today so this may be why we are seeing heightened activity and price movement Obviously, we know there are no earnings, but the markets gonna wanna see how much they spent per share (EPS) and if it’s a beat or miss.
0 · Reply
TDMF123
TDMF123 Jan. 9 at 11:38 AM
$ANIX volume definitely higher than normal PM. Very interesting 🤔
0 · Reply
Gall_t
Gall_t Jan. 9 at 11:03 AM
$ANIX run, boy run
0 · Reply
Aionle
Aionle Jan. 9 at 7:45 AM
$ANIX in Germany 3,70 $ 🚀
1 · Reply
Trader1141
Trader1141 Jan. 8 at 3:05 PM
$ANIX 🥱
0 · Reply
Trader1141
Trader1141 Jan. 8 at 2:05 PM
$ANIX This meeds volume… run still pending $JTAI $ASPC $SMXT $FLYX
0 · Reply
Pedelco
Pedelco Dec. 31 at 12:00 PM
$ANIX some news or Updates in Q1 ?
1 · Reply
RatioRational
RatioRational Dec. 25 at 4:46 PM
$ANIX This ticker is entering a stage where execution quality will overshadow headline narratives. Sequential improvement must start appearing across core metrics. Visible traction across segments would strengthen the thesis. Future re‑rating depends on turning narrative into measurable outcomes.
1 · Reply
justiceforb_85
justiceforb_85 Dec. 23 at 5:19 AM
$ANIX look forward to info on CER-T program in ovarian cancer.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 22 at 11:46 PM
$ANIX Share Price: $3.39 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.71 – $0.86 Potential Upside: 74% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MQuick
MQuick Dec. 19 at 12:28 PM
$GANX there have been a few recent attacks on phase 1 bios $ANIX being one of them extremely similar to what happened to us. I think they are deliberate short attacks.
0 · Reply